Jaguar Health (NASDAQ:JAGX) Shares Pass Above 50 Day Moving Average – Time to Sell?

Jaguar Health, Inc. (NASDAQ:JAGX)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.02 and traded as high as $1.20. Jaguar Health shares last traded at $1.09, with a volume of 425,377 shares traded.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Jaguar Health from a “sell” rating to a “hold” rating in a research note on Friday, September 13th.

Jaguar Health Stock Performance

The company has a current ratio of 1.84, a quick ratio of 1.36 and a debt-to-equity ratio of 1.65. The firm has a fifty day moving average price of $1.02 and a 200-day moving average price of $1.52.

Institutional Trading of Jaguar Health

An institutional investor recently bought a new position in Jaguar Health stock. Perritt Capital Management Inc acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGX) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor acquired 25,000 shares of the biotechnology company’s stock, valued at approximately $90,000. Perritt Capital Management Inc owned 0.51% of Jaguar Health at the end of the most recent reporting period. 12.04% of the stock is owned by institutional investors.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.